Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, New York
- Most recent report
- 8-K, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 397 filings
- On EDGAR
- CIK 1811063
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 27
News 8 of 61
Prospectuses and Registrations 8 of 34
- 424B5 Prospectus supplement for an offering Jun 29, 2026
- FWP Free writing prospectus Jun 26, 2026
- 424B5 Prospectus supplement for an offering Jun 25, 2026
- S-8 Registration statement for an employee plan Mar 3, 2026
- 25-NSE Notice that a security was delisted Feb 10, 2026
- S-8 Registration statement for an employee plan Nov 3, 2025
- S-3ASR Automatic shelf registration Mar 6, 2025
- 424B3 Prospectus supplement for an offering Aug 15, 2024
Proxies 8
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2025
- DEFR14A Aug 13, 2024
- DEF 14A Proxy statement for a shareholder vote Jul 30, 2024
- PRE 14A Preliminary proxy statement May 24, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 4, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 4, 2022
Ownership 8 of 228
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jun 24, 2026
- 4 Insider reported a trade Jun 24, 2026
- 4 Insider reported a trade Jun 24, 2026
- 144 Notice of a proposed sale of restricted stock Jun 23, 2026
- 144 Notice of a proposed sale of restricted stock Jun 23, 2026
- 144 Notice of a proposed sale of restricted stock Jun 23, 2026
Other 8 of 39
- 305B2 Jun 29, 2026
- ARS Annual report sent to shareholders Apr 10, 2026
- ARS Annual report sent to shareholders Apr 8, 2025
- EFFECT Notice that a registration became effective Aug 15, 2024
- CORRESP Reply to SEC staff Aug 12, 2024
- UPLOAD Comment letter from SEC staff Aug 8, 2024
- ARS Annual report sent to shareholders Jul 30, 2024
- UPLOAD Comment letter from SEC staff Jul 16, 2024
Everything here comes from Nuvation Bio Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.